<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77503</article-id><article-id pub-id-type="doi">10.7554/eLife.77503</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-271546"><name><surname>Doorduijn</surname><given-names>Dennis J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271547"><name><surname>Lukassen</surname><given-names>Marie V</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271548"><name><surname>van 't Wout</surname><given-names>Marije FL</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271549"><name><surname>Franc</surname><given-names>Vojtech</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271550"><name><surname>Ruyken</surname><given-names>Maartje</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117945"><name><surname>Bardoel</surname><given-names>Bart W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6450-277X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56803"><name><surname>Heck</surname><given-names>Albert JR</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2405-4404</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-112770"><name><surname>Rooijakkers</surname><given-names>Suzan HM</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4102-0377</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medical Microbiology</institution>, <institution>University Medical Center Utrecht</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Biomolecular Mass Spectrometry and Proteomics</institution>, <institution>Utrecht University</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-190571"><name><surname>Iqbal</surname><given-names>Jameel</given-names></name><role>Reviewing editor</role><aff><institution>DaVita Labs</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>s.h.m.rooijakkers@umcutrecht.nl</email> (SR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e77503</elocation-id><history><date date-type="received"><day>01</day><month>02</month><year>2022</year></date><date date-type="accepted"><day>01</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Doorduijn et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Doorduijn et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77503-v1.pdf"/><abstract><p>The Membrane Attack Complex (MAC or C5b-9) is an important effector of the immune system to kill invading microbes. MAC formation is initiated when complement enzymes on the bacterial surface convert complement component C5 into C5b. Although the MAC is a membrane-inserted complex, soluble forms of MAC (sMAC, or terminal complement complex (TCC)) are often detected in sera of patients suffering from infections. Consequently, sMAC has been proposed as a biomarker, but it remains unclear when and how it is formed during infections. Here, we studied mechanisms of MAC formation on different Gram-negative and Gram-positive bacteria and found that sMAC is primarily formed in human serum by bacteria resistant to MAC-dependent killing. Surprisingly, C5 was converted into C5b more potently by MAC-resistant compared to MAC-sensitive <italic>Escherichia coli</italic> strains. In addition, we found that MAC precursors are released from the surface of MAC-resistant bacteria during MAC assembly. Although release of MAC precursors from bacteria induced lysis of bystander human erythrocytes, serum regulators vitronectin (Vn) and clusterin (Clu) can prevent this. Combining size exclusion chromatography with mass spectrometry profiling, we show that sMAC released from bacteria in serum is a heterogeneous mixture of complexes composed of C5b-8, up to 3 copies of C9 and multiple copies of Vn and Clu. Altogether, our data provide molecular insight into how sMAC is generated during bacterial infections. This fundamental knowledge could form the basis for exploring the use of sMAC as biomarker.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>(639209-ComBact</award-id><principal-award-recipient><name><surname>Rooijakkers</surname><given-names>Suzan HM</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>Aspasia</award-id><principal-award-recipient><name><surname>Rooijakkers</surname><given-names>Suzan HM</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Utrecht Molecular Immunology HUB</institution></institution-wrap></funding-source><award-id>eSTIMATE</award-id><principal-award-recipient><name><surname>Rooijakkers</surname><given-names>Suzan HM</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Netherlands Proteomics Centre</institution></institution-wrap></funding-source><award-id>184.034.019</award-id><principal-award-recipient><name><surname>Heck</surname><given-names>Albert JR</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Independent Research Fund Denmark</institution></institution-wrap></funding-source><award-id>9036-00007B</award-id><principal-award-recipient><name><surname>Lukassen</surname><given-names>Marie V</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All relevant data supporting the findings of this manuscript have been added in the main manuscript and supplemental information. Supporting source data (for figures 1 - 6a and supplements)  have been uploaded to Dryad Digital Repository (doi:10.5061/dryad.g4f4qrfsd). The MS data (in figure 6, figure 6 supplement and figure 7) have been deposited to the ProteomeXchange partner MassIVE database and assigned the identifier MSV000088560 (doi:10.25345/C5QW00).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Doorduijn D</collab></person-group><year iso-8601-date="2022">2022</year><source>Source data for: Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.g4f4qrfsd">https://dx.doi.org/10.5061/dryad.g4f4qrfsd</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.g4f4qrfsd</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Albert J.R. Heck</collab></person-group><year iso-8601-date="2022">2022</year><source>Bottom-up MS of soluble MAC released from bacteria</source><ext-link ext-link-type="uri" xlink:href="https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?accession=MSV000088560">https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?accession=MSV000088560</ext-link><comment>doi:10.25345/C5QW00</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-77503-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>